GO Main Menu Go Main Contents Go Bottom Menu

Celltrion Healthcare receives Health Canada marketing authorization for world’s first subcutaneous formulation of infliximab, Remsima™ SC

등록일 2021-02-01


Cookie technology helps us bring you the best possible experience when you visit this website. If you continue without changing your settings, you are agreeing to the cookies on this website. To learn more about our policy on cookies, please review our privacy policy via the link at the bottom of the page.